John A. Kollins SEC EDGAR Filings (CIK 0001391070)

SEC EDGAR filings, ownership reports, and insider transactions for John A. Kollins.

Business address
Satsuma Pharmaceuticals, Inc., 400 Oyster Point Boulevard, Suite 221, South San Francisco, CA, 94080
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
John A. Kollins has filed 15 SEC EDGAR filings since 05 Mar 2007

Latest Filings

Recent SEC filings for John A. Kollins including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 08 Jun 2023 06 Jun 2023 001-39041
4 Open 4 document View SEC filing for 4 FORM 4 07 Jun 2022 03 Jun 2022 001-39041
4 Open 4 document View SEC filing for 4 FORM 4 07 Dec 2020 03 Dec 2020 001-39041
4 Open 4 document View SEC filing for 4 FORM 4 06 Mar 2020 04 Mar 2020 001-39041
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 12 Sep 2019 12 Sep 2019 001-39041
4 Open 4 document View SEC filing for 4 FINAL FORM 4 KOLLINS 30 Oct 2014 30 Oct 2014 001-36066
4 Open 4 document View SEC filing for 4 KOLLINS 05 Jun 2014 03 Jun 2014 001-36066
4 Open 4 document View SEC filing for 4 FORM 4 - KOLLINS 18 Jul 2013 15 Jul 2013 000-51967
4 Open 4 document View SEC filing for 4 KOLLINS ANNUAL OPTION GRANT 08 Jan 2013 07 Jan 2013 000-51967
4 Open 4 document View SEC filing for 4 KOLLINS FORM 4 21 Jun 2012 20 Jun 2012 000-51967
3 Open 3 document View SEC filing for 3 KOLLINS 04 Jun 2012 01 Jun 2012 000-51967

About this filer

John A. Kollins files with the SEC under CIK 0001391070. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages